CD4 and infection: Patients with advanced HIV disease at the time of starting ART, defined by low CD4 count and World Health Organization (WHO) clinical stage 3 or 4 of infection, are less likely to respond to treatment and have a higher mortality rate compared with those who start treatment earlier [4-6].